Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...

Prescription, Nonprescription and Orphan Drugs

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...

Pharmacovigilance

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

Healthcare Agencies II

Healthcare Agencies II

There are various healthcare agencies in the United States—some of which are managed by religious institutions and others by different government branches.
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources,...

Drug Abuse and Addiction: Pharmacological Phenomena

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...

Opioid Receptors: Overview

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Leveraging Pharmacists Using RE-AIM Framework to Implement Age-Friendly Nursing Home Care.

Journal of the American Medical Directors Association·2026

Same author

Assessing evidence for MTM quality measure development: a scoping review.

The American journal of managed care·2026

Same author

Undermeasured and underused: Could a pharmacy accountability measure increase the use of clozapine?

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026

Same author

Key informant perspectives on facilitators for pharmacist payment of medication therapy management services.

Journal of the American Pharmacists Association : JAPhA·2025

Same author

Awareness and Implementation of the Age-Friendly 4Ms Framework: A Needs Assessment Survey.

Journal of the American Geriatrics Society·2025

Same author

Ketamine to enhance methadone treatment retention in patients with opioid use disorder and co-morbid depression.

The American journal of drug and alcohol abuse·2025

Search research articles

Related Experiment Video

Updated: Jul 9, 2025

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

Assessing suboxone access in community pharmacies: Secret shopper model.

Bethany A DiPaula¹, Catherine E Cooke¹

¹University of Maryland School of Pharmacy, USA.

Exploratory Research in Clinical and Social Pharmacy

|November 29, 2023

Summary

Suboxone availability in Maryland pharmacies is limited, with only 31% having it for immediate pick-up. Many patients may face challenges accessing this crucial medication.

Keywords:

Buprenorphine/naloxone Pharmacies Pharmacists Pharmacy Suboxone

More Related Videos

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs

Published on: November 8, 2024

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones

Published on: February 5, 2018

Related Experiment Videos

Last Updated: Jul 9, 2025

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs

Published on: November 8, 2024

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones

Published on: February 5, 2018

Area of Science:

Pharmacology
Public Health
Health Services Research

Background:

Opioid Use Disorder (OUD) treatment is a public health priority.
Suboxone (buprenorphine/naloxone) is a key medication for OUD management.
Accessibility of Suboxone in community pharmacies impacts treatment adherence.

Purpose of the Study:

To evaluate the availability of Suboxone for dispensing in Maryland community pharmacies.
To identify potential barriers to Suboxone access.

Main Methods:

A cross-sectional study utilizing a secret shopper model.
Contacted 1046 public-facing community pharmacies in Maryland.
In-person visits for pharmacies with limited availability to assess dispensing barriers.

Main Results:

Suboxone was available for immediate pick-up in only 31% (326/1046) of pharmacies.
31% of pharmacies had Suboxone available for immediate pick-up.
Availability varied by region and pharmacist interaction; some pharmacies had limited access.

Conclusions:

Approximately 69% of patients may encounter difficulties obtaining Suboxone in Maryland.
Improved patient education and investigation of pharmacy system barriers are needed.
Addressing these barriers can enhance access to OUD treatment.